Erectile dysfunction Board decisions

The Board denied an initial rating higher than 40 percent for diabetes mellitus and a separate initial rating of 20 percent for erectile dysfunction due to diabetes mellitus.

The Board found that the veteran's erectile dysfunction did not meet the criteria for an initial compensable rating, as there was no evidence of a penile deformity.

The Board denied the veteran's claims for service connection for multiple myeloma, Type I diabetes mellitus, nephropathy, uremia and renal artery stenosis, peripheral neuropathy, diabetic retinopathy, hypertension, and coronary artery disease as due to exposure to herbicides (Agent Orange) during service.

The veteran's claims for increased ratings for hydronephrosis, right pyeloplasty and erectile dysfunction are being remanded due to the need for additional development of his medical records and a new examination.

The Board has granted service connection for liver disease, erectile dysfunction, hypertension, and diabetes mellitus associated with Type II diabetes mellitus. The evaluations are all rated at 20 percent from August 6, 2001.

The Board has restored the previously assigned 100% rating for prostate cancer and granted a compensable initial disability rating for complete erectile dysfunction.

The veteran's claim for a compensable evaluation for erectile impotence is being remanded due to the need for additional development, including obtaining updated medical records and conducting a special genitourinary examination.

The Board has determined that the veteran's erectile dysfunction is due to his service-connected diabetes mellitus, Type II. The depression claim remains pending as it was denied in a prior decision.

The Board has granted service connection for diabetes mellitus and erectile dysfunction with deformity, but denied the claims for higher ratings.

The Board has granted the veteran's claim, finding that his erectile dysfunction is secondary to his service-connected hypertension and resolving all reasonable doubt in favor of the veteran.

The Board has determined that the veteran's claimed conditions are not related to his military service and have denied all of his claims for service connection.

The veteran's claim for a higher rating for adenocarcinoma of the prostate and erectile dysfunction was denied. The RO found that the veteran did not meet the criteria for a compensable rating under VA Schedule for Rating Disabilities.

The veteran's claim of secondary service connection for erectile dysfunction is being remanded due to the need for a VA examination to determine if he currently has penile deformity with loss of erectile power.

The Board found no evidence linking the veteran's erectile dysfunction to service, including his diabetes and hypogonadism. The decision denied the claim for service connection.

The veteran's service-connected diabetes mellitus is rated at 40 percent, and he has separate ratings of 20 percent for each lower extremity peripheral neuropathy. The erectile dysfunction associated with the diabetes mellitus is also separately rated.

The Board granted the veteran's claims for increased ratings for peripheral neuropathy of both lower extremities and erectile dysfunction, with a rating of 20 percent for each condition.

The veteran's erectile dysfunction due to testicular atrophy is granted as service-connected. The veteran's PTSD, which is also service-connected, warrants a 50 percent disability rating. The veteran meets the criteria for a total disability rating based on individual unemployability due to his service-connected disabilities.

The veteran's service connection for hypertension, prostate cancer residuals, and erectile dysfunction as a residual of a prostectomy was granted. The rating for prostate cancer residuals was increased to 10 percent effective February 29, 2000.

The Board has denied the veteran's claims for an initial compensable evaluation for erectile dysfunction secondary to service-connected diabetes mellitus and SMC for loss of use of a creative organ.

The Board denied the veteran's claim for an initial compensable rating for erectile dysfunction due to radical prostatectomy for prostate cancer due to Agent Orange exposure, finding that his disability did not warrant a higher evaluation under Diagnostic Code 7522.